Olpruva Kit
Product Images NDC 72542-400

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Olpruva (NDC 72542-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acer Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Olp00 0003 01)

Chemical structure diagram of sodium phenylbutyrate, showing a benzene ring attached to a butyrate chain with a sodium ion at the terminal end.*

FDA Label Image

Acer Therapeutics Logo (Olp00 0003 02)

FDA Label Image

Acer Therapeutics Logo (Olp00 0003 03)

FDA Label Image

Figure A (Olp00 0003 04)

An illustration labeled Figure A showing a glass containing liquid with a spoon inside. This image appears to demonstrate preparation or administration related to the product.*

FDA Label Image

Figure B (Olp00 0003 05)

An instructional illustration showing a glass with liquid, a stirring stick, and a spoon placed inside the glass. The image is labeled as Figure B, likely indicating a step in preparation or administration directions for the OLPRUVA oral kit.*

FDA Label Image

Figure C (Olp00 0003 06)

An instructional line drawing showing a person's hand placing an item into a segmented organizer or tray within a kit. The image is labeled as Figure C and illustrates part of the process for organizing or storing the kit contents.*

FDA Label Image

Figure D (Olp00 0003 07)

Instructional line drawing depicting a hand placing a blister pack or card into a box or pouch, likely illustrating how to assemble or store components of the OLPRUVA oral kit by Acer Therapeutics Inc.*

FDA Label Image

Figure E (Olp00 0003 08)

OLPRUVA oral kit packaging label shows a Mix-Aid compounding reagent container included for use with the product. The label contains usage directions for the Mix-Aid, including how to add water and mix before combining with OLPRUVA. The label features the Acer Therapeutics Inc. logo and highlights that the Mix-Aid is for oral use only.*

FDA Label Image

Figure F (Olp00 0003 09)

An instructional illustration showing a hand holding a Mix-Aid packet above a container, likely demonstrating preparation steps for an oral kit. The Mix-Aid packet label includes text and a logo, suggesting it is part of the OLPRUVA sodium phenylbutyrate oral kit by Acer Therapeutics Inc.*

FDA Label Image

Figure G (Olp00 0003 10)

An instructional illustration showing a packet labeled OLPRUVA (sodium phenylbutyrate) being poured into a cup with liquid and a spoon, demonstrating preparation or mixing of the oral medication kit by Acer Therapeutics Inc.*

FDA Label Image

Figure H (Olp00 0003 11)

An instructional diagram labeled Figure H showing a packet labeled with text being poured into a glass containing liquid and a stirring utensil. This likely represents preparation of an oral medication from a powdered form into a liquid solution.*

FDA Label Image

Figure I (Olp00 0003 12)

An instructional illustration showing a person drinking from a glass, demonstrating oral administration.*

FDA Label Image

Figure J (Olp00 0003 13)

Illustration labeled Figure J depicting a glass of liquid with a spoon stirring or mixing contents near the bottom, indicated by an arrow. The image appears to instruct or demonstrate mixing a substance in a glass.*

FDA Label Image

Figure K (Olp00 0003 14)

An instructional illustration showing a person drinking from a glass, likely demonstrating the oral administration of a medication or solution.*

FDA Label Image

Acer Therapeutics Logo (Olp00 0003 15)

FDA Label Image

Principal Display Panel – Mix-aid Label (Olp00 0003 16)

Label of Mix-Aid suspending agent packet for use with OLPRUVA (sodium phenylbutyrate) oral suspension. Each packet weighs 0.11 oz (3.1 g). The label includes directions to mix full packet contents with water to thicken the suspension. Nutrition facts state 10 calories and minimal sodium per serving. Manufactured for Acer Therapeutics Inc.*

FDA Label Image

Principal Display Panel (2 g Carton Label)

Packaging label for OLPRUVA 2g (sodium phenylbutyrate) for oral suspension, a human prescription drug kit by Acer Therapeutics Inc. The label features yellow and white colors with the product name, strength (2g), and directions for use. The kit contains 90 dosage envelopes, each with a 2 gram packet of OLPRUVA and one Mix-Aid packet. Storage instructions are provided on the label.*

FDA Label Image

Principal Display Panel (2 g Pouch Label)

Label for OLPRUVA (sodium phenylbutyrate) oral suspension, displaying a 2 g per packet strength. The label indicates Rx only status, recommended dosage per prescribing info, and safety instructions to keep out of reach of children. The product is labeled by Acer Therapeutics Inc. and includes a barcode and NDC 72542-002-01.*

FDA Label Image

Principal Display Panel (2 g Envelope Label)

Packaging label for OLPRUVA 2g (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The label features the product name, dosage strength of 2 grams, and mentions each envelope contains one 2 gram packet and one Mix-Aid packet. It includes storage instructions and barcodes on a white background with yellow decorative elements.*

FDA Label Image

Principal Display Panel (3 g Carton Label)

Packaging label for OLPRUVA (sodium phenylbutyrate) oral suspension kit, containing 3g packets, labeled for prescription use. The carton prominently displays the brand name, generic name, dosage strength of 3 grams, and usage as an oral suspension. The labeler is Acer Therapeutics Inc. Additional storage and usage instructions, as well as regulatory information, are printed on the box.*

FDA Label Image

Principal Display Panel (3 g Pouch Label)

Label for OLPRUVA (sodium phenylbutyrate) oral suspension powder kits, each packet containing 3 grams of sodium phenylbutyrate equivalent to 2.63 grams of phenylbutyrate. Label includes NDC 72542-003-01, dosing note to see prescribing information, and safety warning to keep out of reach of children. Manufactured by Acer Therapeutics Inc.*

FDA Label Image

Principal Display Panel (3 g Envelope Label)

Packaging label for OLPRUVA (sodium phenylbutyrate) oral suspension 3 gram kit. The label includes a 3 gram dosage indication, instructions to see accompanying patient instructions for use, and storage information. The labeler is Acer Therapeutics Inc., located in Newtown, MA.*

FDA Label Image

Principal Display Panel (4 g Carton Label)

Packaging label for OLPRUVA 4g (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The carton features the product name, strength, and dosage form prominently on multiple panels. The front panel includes dosing information, storage instructions, and manufacturer details. The design uses teal and white colors with a wave graphic and the Acer Therapeutics logo.*

FDA Label Image

Principal Display Panel (4 g Envelope Label)

Packaging label for OLPRUVA 4g (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The label includes product name, active ingredient, dosage form, strength, and storage instructions. The box features a teal and white color scheme with the manufacturer logo and barcode visible.*

FDA Label Image

Principal Display Panel (5 g Carton Label)

Packaging label for OLPRUVA 5g (sodium phenylbutyrate) oral suspension kit, a human prescription drug by Acer Therapeutics Inc. The design features the product name, active ingredient, dosage strength 5g, and storage instructions. The label includes regulatory information, dosage details, and a barcode, with a red and white color scheme accented by the Acer Therapeutics logo.*

FDA Label Image

Principal Display Panel (5 g Envelope Label)

Carton packaging label for OLPRUVA 5g oral suspension kit containing sodium phenylbutyrate. The front panel displays the product name OLPRUVA and strength 5g prominently in red, with the active ingredient noted below. The labeler is Acer Therapeutics Inc. Additional text indicates the kit contains packets for preparation and storage instructions, alongside a barcode and storage information.*

FDA Label Image

Principal Display Panel (6 g Carton Label)

Label and carton design for OLPRUVA 6g (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The label features dosage strength 6g prominently, with instructions for use and storage information. The design includes purple wave graphics and the OLPRUVA logo with a yellow sun burst icon.*

FDA Label Image

Principal Display Panel (6 g Envelope Label)

Packaging label for OLPRUVA 6g (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The label includes dosage strength, instructions indicating each envelope contains two 3 gram packets and one Mix-Aid packet, along with storage conditions and barcode. It also shows a purple wave design element and labeler information.*

FDA Label Image

Principal Display Panel (6.67 g Carton Label)

Packaging label for OLPRUVA (sodium phenylbutyrate) oral suspension kit. The label highlights the 6.67 g strength and includes manufacturer Acer Therapeutics Inc. The design features a blue and white color scheme with a wave graphic and dosage information. The kit contains 90 dosage envelopes for oral use.*

FDA Label Image

Principal Display Panel (6.67 g Envelope Label)

Box packaging for OLPRUVA (sodium phenylbutyrate) oral suspension kit, containing 6.67g. The label includes the product name, strength, dosage form, and directions to see accompanying patient instructions and prescribing information. The labeler is Acer Therapeutics Inc., with NDC 72542-667-02. Additional warnings include keeping out of reach of children and storage instructions.*

FDA Label Image

Principal Display Panel (3.67 g Pouch Label)

Packaging label for OLPRUVA (sodium phenylbutyrate) oral suspension kit by Acer Therapeutics Inc. The label indicates a 3.67 g amount per packet, with a note to see prescribing information for dosage. It includes the NDC 72542-367-01 and a caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.